Zithromax-SR 2g, Special Investigation (Regulatory Post Marketing Commitment Plan)

• Status: Completed
• Trial end date: 2011-01-01
• Target enrollment: 0
• Participant gender: All

Summary

To collect the efficacy and safety information of Zithromax-SR related to their appropriate use in daily practice.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Azithromycin

Criteria

Inclusion Criteria:

• Male or female subjects diagnosed with skin and soft tissue infection, sexually-transmitted infection, and infection of the oral.

• Subjects must have no prior experience with Azithromycin SR.

Exclusion Criteria:

• Patients not administered Azithromycin SR.